Acorda reports $18.8 million loss
-
- August
- 5
Acorda Therapeutics Inc., the pharmaceutical company based in Hawthorne, said this morning it lost $18.8 million, or 58 cents a share, during the quarter that ended in June.
During the corresponding quarter in 2007, the company, which markets Zanaflex, a treatment for involuntary muscle movements caused by multiple sclerosis and spinal injuries, lost $8.2 million, or 33 cents a share.
Net sales rose to $11.36 million from $9.48 million.
The company is also seeking to develop Fampridine-SR, a drug to help people with multiple sclerosis walk.
Dr. Ron Cohen, the president and chief executive of the company, said in a statement released by the company. “Acorda continued to achieve important milestones in this quarter.â€
This entry was posted
on Tuesday, August 5th, 2008 at 8:46 am by Allan Drury.
You can follow any responses to this entry through the RSS 2.0 feed.
Share and Enjoy: 
| 
Print
| 
Email
